Citizens Financial Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-1,197
Closed -$203K – 469
2022
Q4
$203K Sell
1,197
-9
-0.7% -$1.63K 0.01% 409
2022
Q3
$226K Buy
+1,206
New +$254K 0.01% 378
2022
Q2
– Sell
-1,439
Closed -$271K – 453
2022
Q1
$271K Buy
1,439
+9
+0.6% +$1.71K 0.01% 384
2021
Q4
$379K Hold
1,430
– – 0.01% 332
2021
Q3
$413K Buy
1,430
+8
+0.6% +$2.05K 0.02% 309
2021
Q2
$284K Hold
1,422
– – 0.01% 300
2021
Q1
$276K Hold
1,422
– – 0.01% 261
2020
Q4
$272K Buy
+1,422
New +$259K 0.02% 250
2020
Q3
– Sell
-1,422
Closed -$176K – 782
2020
Q2
$176K Sell
1,422
-83
-6% -$9.76K 0.01% 291
2020
Q1
$145K Sell
1,505
-73
-5% -$7.05K 0.01% 295
2019
Q4
$146K Buy
+1,578
New +$133K 0.01% 286

Other funds holding RGEN

Citizens Financial Group's RGEN Position: Q1 2023 in Review

Citizens Financial Group sold out of Repligen (RGEN) in Q1 2023, closing a stake of 1,197 shares — an estimated $203K sold.

Citizens Financial Group first reported a position in RGEN in Q4 2019 and held it in 11 quarters. The position peaked at $413K in Q3 2021. 447 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.

  • Citizens Financial Group reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
  • Citizens Financial Group sold 1,197 Repligen shares in Q1 2023, an estimated $203K.
  • Citizens Financial Group first reported a position in Repligen in Q4 2019 and held it in 11 quarters.
  • Citizens Financial Group's Repligen position peaked at $413K in Q3 2021.
  • 447 funds tracked by Wall St. Rank held Repligen as of Q1 2023.

Based on Citizens Financial Group's 13F filing for Q1 2023, filed 10 May 2023.